|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.66 CHF | -0.47% |
|
+24.24% | +79.16% |
| 07-15 | Frankfurt stocks close: Dax slips by the narrowest margin below 25,000 points | DP |
| 07-15 | DOCMORRIS : UBS remains a Sell rating | ZD |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 521.2 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 80.23% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 722.4 | 757.8 | 752 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 69.27% | 4.91% | -0.77% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -6.71x | -12.7x | -29.5x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.65x | 1.66x | 1.9x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.3x | 0.5x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.43x | 0.38x | 0.35x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.59x | 0.55x | 0.51x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -38x | 41.2x | 15.8x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -10.9x | -21x | -67.4x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -10.2x | -23.9x | -52.3x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -9.76% | -4.19% | -1.91% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.59 | -0.8381 | -0.3609 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,225 | 1,376 | 1,470 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -19 | 18.39 | 47.73 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -66.47 | -36.04 | -11.15 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -84.01 | -46.25 | -26.01 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 201.2 | 236.7 | 230.8 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 10.66 | 10.66 | 10.66 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,889 | - | - |
| Announcement Date | 3/24/22 A | 3/24/23 A | 3/20/24 A | 3/12/25 A | 3/18/26 A | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.71x | 0.59x | -38.02x | -.--% | 646M | ||
| 17.52x | 0.73x | 11.43x | -.--% | 15.14B | ||
| 22.93x | 0.91x | 15.97x | 0.99% | 6.93B | ||
| 16.6x | 0.75x | 7.78x | 2.25% | 6.13B | ||
| 13.17x | 0.84x | 6.06x | 3.25% | 3.73B | ||
| 14.25x | 0.59x | 4.69x | 4.85% | 3.12B | ||
| 15.8x | 0.96x | 7.22x | 4.06% | 3.25B | ||
| 14.04x | 1.2x | 7.28x | 5.49% | 3.15B | ||
| 39.53x | - | - | - | 2.57B | ||
| Average | 16.35x | 0.82x | 2.80x | 2.61% | 4.96B | |
| Weighted average by Cap. | 18.19x | 0.81x | 9.28x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
















